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Crystal Structure of Paromomycin Docked into the
Eubacterial Ribosomal Decoding A Site
bind to RNA, aminoglycosides (Figure 1) have attracted
great attention since their discovery 50 years ago [7, 8].
They still constitute critical weapons in the continual
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Mode´lisation et simulations des Acides Nucle´iques, fight against bacterial infections [9]. The ribosome is
thought to be the primary target of aminoglycosides thatUPR 9002
15 rue Rene´ Descartes have been shown to footprint to the aminoacyl decoding
site (A site) of the ribosomal 16S RNA [10]. Most impor-Strasbourg Cedex 67084
France tantly, it has been shown that when the A site motif is
inserted in different RNA fragments, the A site presents
the same footprint in the presence of antibiotics as it
does when it is within the full 16S rRNA [11-14]. In a
Summary recent series of NMR structures, Puglisi and coworkers
identified key interactions in the binding of aminoglyco-
Background: Aminoglycoside antibiotics interfere with sides to an Escherichia coli A site fragment model [15-
translation in both gram-positive and gram-negative 18]. Very recently, a crystallographic structure of a com-
bacteria by binding to the tRNA decoding A site of the plex between the bacterial ribosomal 30S subunit and
16S ribosomal RNA. an aminoglycoside has been obtained at 3.05 A˚ resolu-
tion [19]. Here, we report the detailed structure of an
RNA fragment containing two minimal A sites com-Results: Crystals of complexes between oligoribo-
plexed with two paromomycin molecules solved bynucleotides incorporating the sequence of the ribosomal
X-ray crystallography at 2.5 A˚ resolution. The close con-A site of Escherichia coli and the aminoglycoside paro-
tacts between the paromomycin functional groups andmomycin have been solved at 2.5 A˚ resolution. Each
both the RNA and its hydration shell enlighten our under-RNA fragment contains two A sites inserted between
standing of the micromolar binding specificity of amino-Watson-Crick pairs. The paromomycin molecules inter-
glycosides to the prokaryotic A site.act in an enlarged deep groove created by two bulging
and one unpaired adenines. In both sites, hydroxyl and
ammonium side chains of the antibiotic form 13 direct
Results and Discussionhydrogen bonds to bases and backbone atoms of the
A site. In the best-defined site, 8 water molecules medi-
Overall Description of the Complexate 12 other hydrogen bonds between the RNA and the
The structure of an 18 bp helix containing two minimal Aantibiotics. Ring I of paromomycin stacks over base
sites (13 nucleotides) complexed with two paromomycinG1491 and forms pseudo-Watson-Crick contacts with
molecules was solved to 2.5 A˚ resolution (Table 1; FigureA1408. Both the hydroxyl group and one ammonium group
2). The two A sites are separated by four GC pairs.of ring II form direct and water-mediated hydrogen
Paromomycin binding occurs in an enlarged deepbonds to the U1495oU1406 pair. The bulging conformation of
groove consisting of four base pairs and two bulgingthe two adenines A1492 and A1493 is stabilized by hydrogen
adenines; this binding occurs without major distortionbonds between phosphate oxygens and atoms of rings
of the double helix (Figure 2b). The electron density forI and II. The hydrophilic sites of the bulging A1492 and
each antibiotic is well defined, but one of the two sitesA1493 contact the shallow groove of GC pairs in a sym-
(site 1) is better ordered (Figure 3a). The other site (sitemetrical complex.
2) displays some lack of connectivity along the RNA
backbone at 0.9 . The root-mean-square deviation
Conclusions: Water molecules participate in the bind- (rmsd) between the two sites is 0.8 A˚ (Table 2). Crystal
ing specificity by exploiting the antibiotic hydration shell packing involves hydrogen bonds between the two bulg-
and the typical RNA water hydration patterns. The ob- ing adenines and the shallow groove of two GC pairs
served contacts rationalize the protection, mutation, belonging to a neighboring molecule. The bulging ade-
and resistance data. The crystal packing mimics the nines are not perfectly parallel but form a wedge (Figures
intermolecular contacts induced by aminoglycoside 3a and 3b). The temperature B factors range from 21 to
binding in the ribosome. 95 A˚2 for the complex; the highest values (70–95 A˚2)
correspond to the terminal base pairs where the 5 cyto-
sine is too disordered to be observed in the density map.Introduction
Interestingly, the lowest thermal factors in the complex
(21–40 A˚2) are observed for rings I, II, and III of paromo-RNA molecules can adopt highly structured and intricate
mycin and for the central GC pairs. Here, for clarity,three-dimensional folds [1-4]. Some of these complex
we will focus our description on site 1 using the E. colistructural motifs constitute therapeutic targets [5, 6].
numbering (see inset in Figure 2a).Among the different classes of compounds known to
2 Correspondence: e.westhof@ibmc.u-strasbg.fr Key words: aminoglycoside; crystal structure; ribosomal RNA
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Figure 1. Chemical Structures of Antibiotics
Belonging to the Aminoglycoside Family
The aminoglycosides contain the neamine
core (green), a two-ring system comprising
2-deoxystreptamine (ring II) glycosylated at
position 4 by a six-membered aminosugar
(ring I) of the glycopyranoside series. Ribosta-
mycin, neomycin B, and paromomycin result
from addition of supplementary sugars at po-
sition 5 (yellow), while tobramycin results
from addition of an aminosugar at position
6 (blue). The aminoglycosides are shown as
polycationic antibiotics with (for paromomy-
cin) the conformation observed in the present
structure.
The Interactions between Paromomycin molecule within the A site. Rings I and II interact with
the sugars and the phosphates of the two bulging ade-and the A Site
The antibiotic is anchored in the deep groove of the RNA nines by making both direct (three contacts involving
O3’, O4’, and N3) and water-mediated hydrogen bondsby direct and water-bridged hydrogen bonds (Figures 3b
and 4a). While exhibiting sometimes high propeller-twist (three contacts involving N2’ and O6’) (Table 2; Figures
3 and 4a).values (2–3 times higher than for standard base pairs),
every base pair except two UoU pairs is of the standard Ring II interacts with the deep-groove hydration shell
of the G1405C1496 pair located in the upper part of the AWatson-Crick type (Figures 4b–4f). The two adenines
A1492 and A1493 (which fully bulge out of the helix) and the site (Figure 4b). One of the most interesting contacts
occurs with the hydroxyl group O6 of paromomycin: itUoU pairs are responsible for a slight bending of the
double helical axis (Figure 3). Despite its nonplanarity, forms a single hydrogen bond to a water molecule that
is itself bound to the O4 atoms of the U1495oU1406 pairring I of paromomycin stacks upon the following G1491
(Figure 4f) and is contacted by A1408 via its Watson-Crick and to the O6 atom of G1405 (Figure 4c). In the U1495oU1406
pair, the uracils are shifted from a symmetrical to aedge (Figure 4e). Furthermore, ring I donates two intra-
molecular hydrogen bonds to hydroxyl groups O4’’ and bifurcated pair with the glycosidic bond of U1406 at 90
from that of U1495 (Figure 4c). A similar pair has beenO5’’ of ring III (Table 2; Figure 4a); these bonds probably
help to maintain the conformation of the paromomycin observed at positions 32–38 in E. coli tRNAGln complexed
Table 1. Data Collection and Structure Determination
Crystallographic Data
Space group P212121
Unit cell parameters (A˚) a  33.0, b  45.9, c  95.3
Wavelength (A˚) 0.934
Resolution range used for refinement (A˚)a 10–2.5 (2.59–2.50)
Number of unique reflections used in refinement 5,278
Redundancy 9.7
Average I/a 24.4 (6.4)
Completeness (%)a 95.0 (97.4)
Rsym (%)a,b 5.5 (23.0)
Rmsd for bonds (A˚) 0.011
Rmsd for angles () 1.6
Average B factor (A˚2) 52.7
R factor (%)c 20.6
Rfree (%)d 24.7
a Values for last shell are given between parentheses.
b Rsym  |I  I|/I, where I is the measured intensity of each reflection and I is the intensity averaged from multiple observations
of symmetry-related reflections.
c R factor  ||Fo|  |Fc||/|Fo|
d R factor calculated using 7.5% of the reflections omitted from the refinement.
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Figure 2. Overall View of the Crystallized
Complex
(a) Secondary structure of the duplex. Base
pairs are symbolized with “” (3 hydrogen
bonds) or “–” (2 hydrogen bonds) for Watson-
Crick pairs and “o” for non-Watson-Crick
pairs. The dashed line separates the two simi-
lar A site models (sites 1 and 2). Interacting
paromomycin molecules that adopted the
conformation observed in the crystal are
drawn as ball-and-sticks colored by atom
types. Nucleotides in red are contacted di-
rectly by the paromomycin molecules. The
unobserved cytosine on the 5 end is shaded.
The inset on the left gives the corresponding
E. coli numbering for the common A site ele-
ments (13 nucleotides).
(b) Ribbon stereo view showing the three-
dimensional structure of the duplex. The two
complexed paromomycin, the four bulging
adenines (15, 16, 36, and 37), and the two
adenines (6 and 27) contacting ring I of the
two paromomycin molecules are drawn as
ball-and-sticks. This and other figures (2b
and 3–7) were prepared with Drawna [60].
to its cognate synthetase [20] and in the structure of All the direct contacts responsible for the paromomy-
cin binding to the site 1 are also observed in site 2 ofthe spliceosomal U2B”-U2A’ protein complex bound
to a fragment of U2 RNA [21]. In the latter structure, the crystallized complex (Table 2; Figure 4a). Further-
more, the water molecule linking the hydroxyl O6 of ringthe ammonium group of a lysine side chain replaces the
water molecule observed in the deep groove of the II to the UoU pair is observed in both sites. In summary,
paromomycin contains five ammonium groups, amongU1495oU1406 pair. The pairing is akin to the bifurcated GoU
pair [22, 23] observed in the bacterial loop E structure which only the ammonium N3 on ring II is fully dehy-
drated. The ammonium N3 is indeed protonated despite[24], where a water molecule links the N3 of the U to
the substituent at position 2 (N2 in the GoU pair and O2 its lower pKa (pKa  5.7; see [25]): it gives two hydrogen
bonds to two anionic phosphate oxygens (O1P of A1493in the UoU pair).
Besides the intramolecular interaction with ring I, ring and O2P of G1494) and one hydrogen bond to the N7 of
G1494 (Figure 4d). The ammonium N2’, which forms theIII bridges the two RNA strands together: O2’’ accepts
one hydrogen bond from N4 of C1407 (Figure 4d), and intramolecular contact between rings I and III, still has
one water molecule in its coordination shell. The ammo-O5’’ points its hydrogen atom to N7 of G1491 (Figure 4f).
Ring IV constitutes the less-ordered part of the antibiotic nium N1 on ring II, in contact with the UoU pair, is coordi-
nated to two water molecules (Figure 4a). The two am-but contributes to the overall binding of the other rings
by making hydrogen bonds to the phosphate oxygen monium groups of ring IV are strongly hydrated since
only N2’’’ forms a single direct contact to an anionicatoms of G1405 (Table 2; Figures 3b and 4a). Neither the
ammonium N6’’’ nor the bridging oxygen atom between phosphate oxygen atom (and to a water molecule in site
2; Table 2). As previously suggested [26, 27], the partialthe cycles are observed to form any hydrogen bonds.
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Figure 3. Detailed View of the A Site
(a) Stereo view of the electron density map
around the A site (site 1). A-weighted
3Fo2Fc maps contoured at 1.4 are colored
green for the RNA chains and the water mole-
cules and orange for the paromomycin.
Atoms of the RNA chains are shown in gray,
water oxygen atoms are in red, and paromo-
mycin atoms are in blue. This figure was made
using Setor [61].
(b) Same view as in (a) but with color code
as in Figure 1b. All the atoms of the A site
are depicted as ball-and-sticks, with water
oxygens in red. The green dashed lines indi-
cate some of the direct and water-mediated
contacts between the antibiotic and the RNA.
negative charges on the carbonyl oxygen atoms of the bound to the Hoogsteen sites of G1405 (Figure 4b) are
commonly seen around G residues [31]. Similarly, theUoU pair, the guanines, and the phosphate oxygens
enable complementary electrostatic contacts with at water molecules bound to the shallow groove side of
the UoU pair and of G1494 (Figures 4c and 4d) have beenleast three of the five ammonium groups of the paromo-
mycin molecule. previously observed [20, 31]. Interestingly, the number
of water molecules at the interface between the paromo-
mycin and the RNA is within the range of the averageRoles of the Water Molecules
in the Recognition Process number of water molecules (12) observed at the inter-
face of RNA-protein complexes [32]. It is stressed recur-Fifty-four water molecules are observed in the present
structure. This number corresponds roughly to the aver- rently that water is an integral part of nucleic acid struc-
ture [33]. The present structure contributes further toage number of molecules observed at this resolution
around an RNA duplex (140 in a 46 nucleotide duplex the notion that water is also an integral part of RNA-
antibiotic interactions, and that water structure and dy-at 2.3 A˚ resolution [28], 50 in a 24 nucleotide duplex at
2.6 A˚ resolution [29], and 16 in a 32 nucleotide duplex namics should be considered in drug design.
at 2.5 A˚ resolution [30]). A careful examination of the
density maps reveals that 46 of them are observed at Comparisons with Previous NMR
and X-Ray Structuresa contour above 0.6  (38 are still clearly observed at
1.0 ). Only about 8 water molecules are observed above The structure of the A site of the 30S particle in the
presence of the antibiotic [19] is similar to the two sites0.35 , mostly around site 2 where the density is not so
well defined. of the present structure (rmsd below 1 A˚; Table 3; Figures
5a and 5b). However, the rmsd of the X-ray structuresIn the best defined site (site 1), we clearly see 8 water
molecules mediating 12 contacts between the hydro- with the NMR structure of the complex [15] are above
2.5 A˚, i.e., of the same order of magnitude as thosephilic groups of the paromomycin and the A site (Table
2; Figure 4a). Four of these contacts link paromomycin between the X-ray structures with and without antibiotic
[19, 34]. The bulging adenines are observed to adoptto phosphate oxygens on the bulged-adenine side, and
five other contacts interact with the opposite strand via different wedged conformations. Thus, the rmsd calcu-
lated for the bulged adenines between the two sites isatoms at positions 6 and 7 of the purines (Table 2). Two
water-mediated contacts occur in both sites; one links approximately 2.0 A˚, while that between each of the
sites and the 30S particle in the presence of antibioticring II to the UoU pair, and one connects ring III to the
Hoogsteen side of A1408. In addition, three intraparomo- is either close to 0.8 A˚ or close to 2 A˚ (Table 3). Further-
more, the rmsd between the X-ray structure of the 30Smycin contacts are mediated by water molecules. Some
of these water molecules are common to the hydration particle with IF1 [35] and the X-ray structures in the
presence of the antibiotic are close to 3.8 A˚. Finally, theshell of the RNA. For example, the water molecules
Complex between Paromomycin and Bacterial A Site
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Table 2. List of the Direct and the Water Contacts between the Paromomycin and the A Site
Site 1 Site 2 30S X-Ray NMR
(Present (Present Structure Structure
Direct Contacts Structure) Structure) [19] [15]
X d1 Ya d1 d1 d1 d1.........
N2’ ........ O4’’ 3.21 3.25 2.63 2.75
N2’ ........ O5’’ 3.12 3.33 2.92 3.94
O3’ ........ O2P(A1492) 2.90 3.13 3.10 3.18
O4’ ........ O2P(A1493) 2.54 2.84 2.54 3.80
O5’ ........ N6(A1408) 3.16 3.22 3.29 —
O6’ ........ N1(A1408) 2.53 2.57 2.69 —
N1 ........ O4(U1495) 2.82 2.72 2.74 3.05
N3 ........ O1P(A1493) 3.13 3.17 2.95 —
N3 ........ N7(G1494) 2.78 2.51 3.01 3.44
N3 ........ O2P(G1494) 3.12 3.17 2.64 —
C4 ........ O6(G1494) 3.28 3.16 3.72 —
O2’’ ........ N4(C1407) 2.73 3.07 2.96 —
O5’’ ........ N7(G1491) 2.71 2.74 2.41 3.20
N2’’’ ........ O2P(G1405) 2.96 3.18 — —
O4’’’ ........ O1P(G1405) 3.77 3.59 3.46 —
Water Bridges Site 1 (Present Structure) Site 2 (Present Structure)
X d1 W d2 Ya d1 d2 d1 d2.......... ...........
N2’ ............W44....................O2P(A1492) 3.47 2.57 — —
W44....................O2P(G1491) — 3.24 — —
W44....................W52 — 3.29 — —
N2’ ............W14....................O1P(A1493) 3.27 2.89 — —
W14....................W26 — 3.20 — —
O3’ ............W44 3.51 — — —
O6’ ............W32....................O2P(A1493) 2.77 3.05 — —
W32....................W28 — 2.92 — —
N1 .............W13....................O6(G1405) 2.82 2.75 — —
N1 .............W20....................W12 2.68 2.71 — —
O6 .............W8(W54) ............O4(U1406) 2.62 2.59 2.62 2.41
W8(W54) ............O4(U1495) — 2.98 — 3.17
(W54...................W7) — — — 3.22
O6 .............W13....................O6(G1405) 3.53 2.75 — —
W13....................W19 — 2.87 — —
O6 .............W19....................O6(G1407) 3.21 3.19 — —
W19....................N7(G1407) — 2.81 — —
W19....................W13 — 2.87 — —
C2’’ ...........W9(W2) ..............N6(A1408) 3.26 2.56 3.34 3.48
W9(W2) ..............N7(A1408) — 3.08 — 3.29
W9(W2) ..............W51 — 2.73 — —
O2’’ ...........(W7.....................N2’’’) — — 3.14 3.37
O3’’’ ..........W15....................W47 3.49 3.78 — —
a X stands for a paromomycin atom and Y for a paromomycin atom, an RNA atom, or a water molecule. The bridging water molecule is
represented by W. The water molecules observed in site 2 are indicated between parentheses.
List of the contacts within a distance of 2.5–4 A˚ observed between the paromomycin and the A site in the different NMR [15] and crystallographic
structures (present work, [19]). Distances are given in A˚ when a hydrogen bond is observed. A dash means the contact does not occur.
effect of antibiotic binding leads to structures with rmsd This is apparent from the rmsd calculated on the antibi-
otics alone in the molecules superposed with only thebeyond 6 A˚ compared to the X-ray structure without
antibiotic. base pairs of the site (without the adenines); the rmsd
are beyond 3.0 A˚ (Table 2).The NMR study [15] correctly identified most of the
contacts (Table 2). The contacts involving two ammo- In addition to the absence of water molecules, none
of the previous NMR or X-ray structures mentioned thenium groups of ring II as well as the intramolecular hy-
drogen bond between the ammonium N2’ of ring I and direct interactions between ring I and A1408. These key
interactions are nevertheless responsible for the greaterthe oxygen atom O4’’ of ring III were already observed.
These contacts as well as additional contacts involving part of the aminoglycoside specificity toward the pro-
karyotic A site (see discussion in the next section).hydroxyl groups are also partially seen in the X-ray stud-
ies [19]. However, nine of the direct contacts observed
by NMR between rings I and II and the RNA are not Comparisons with the Probing
and Resistance Dataobserved in the present structure. These differences
stem from the very different conformations adopted by Chemical probing experiments on complete ribosomal
RNA and on A site models have shown that atomsA1492, A1493, and ring IV in the NMR and X-ray structures.
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Figure 4. Description and Analysis of the
Contacts between Paromomycin and the
RNA Fragment
(a) Structure adopted by the paromomycin
molecule inside the A site of the duplex (site
1). Colors correspond to atom types as in
Figure 1a. Ring numbers (I–IV), oxygen (red),
and nitrogen (blue) names are specified. The
RNA atoms involved in these contacts are
indicated with the E. coli numbering. “W”
stands for the oxygen of a water molecule.
Hydrogen bonds are represented by dashed
lines and accompanied by each correspond-
ing distance in italic. The underlined atoms
represent the contacts that were also ob-
served in site 2.
(b–f) Atomic details around each base pair in
interaction with the paromomycin within the
A site (nomenclature as in Figure 1a; colors
as in Figure 2b) as viewed down the helical
axis. Hydrogen bonds are represented by
black dashed lines. The E. coli numbering and
the ring numbers are also indicated. Arrows
point to the atoms connected to the other
parts of the antibiotic. Each base pair is ob-
served to be globally orthogonal to the ring
interacting with it except for A1408, which is
parallel to ring I.
N7(G1405), N1 and N7(A1408), N7(G1491), N7(G1494), N1, and The higher resolution structure presented in this paper
enables an understanding of the role of A1408 as a deter-the phosphate oxygens of A1492 and A1493 are protected
from chemical attack upon the binding of paromomycin minant for the binding specificity of antibiotics con-
taining an aminosugar as ring I. For example, an A1408Gand similar aminoglycosides [10, 11, 13]. Indeed, in the
crystal structure, N1(A1408) and N7(G1494) as well as the mutation (as in eukaryotic rRNA) would deprive ring I of
a specific and strong anchoring point by preventing thephosphate oxygens of A1492 and A1493 form direct hydro-
gen bonds with the invariant neamine part of the amino- formation of the pseudo-trans Watson-Crick pair be-
tween ring I and residue 1408, thus accounting for theglycoside (rings I and II). The binding of hydroxyl O5”
to N7(G1491) explains the better affinity and specificity lower activity of paromomycin on such mutants [36].
Methylation at N1 of A1408 confers strong resistance toexhibited by the three- and four-ring aminoglycosides
of the paromomycin subclass toward the A site [17]. ribostamycin, neamine, and kanamycin but a weak resis-
tance to neomycin and paromomycin [37]. The first threeThe contact with ring I is particularly interesting since
in neomycin, gentamicin, and kanamycin the hydroxyl compounds are shorter and thus would almost exclu-
sively rely on the direct contacts with A1408 for binding,O6’ of paromomycin is replaced by an ammonium group
still able to form the same hydrogen bond to A1408. The while the highly derivatized aminoglycosides could dis-
play some alternative and weaker binding modes.ammonium groups in ring II that bind to N7(G1494) and
O4(U1495) are invariant in this whole family of 4,5- and The naturally occurring 5-methylation of C1407 does not
introduce any change in the aminoglycoside binding4,6-linked aminoglycosides (Figure 1), thus explaining
the loss of tight binding that occurs when one of these mode [10, 38]. Indeed, a methyl group at that position
would occupy a pocket not involved in close interactionsbases is mutated. Besides, at the level of the bifurcated
UoU pair, only the mutation U1495A, which therefore between the RNA and the antibiotic (Figure 4d). Super-
imposition of rings I and II present in both the 4,5-linkedinvolves the residue in direct contact with the antibiotic,
results in loss of tight binding [13]. A strong interference (neomycin, paromomycin) and 4,6-linked (tobramycin,
gentamicin, kanamycin) aminoglycosides shows thatinduced by methylation at N1 of A1492 and A1493, reported
recently to disrupt paromomycin binding [14], cannot similar interactions can form between rings I and II and the
RNA. However, the difference in the linkage makesbe explained by the present structure. Methylation intro-
duces a positive charge on the adenines that could re- the third ring interact directly with N7 of G1405 through
the ammonium N3” (Figure 6). This could explain theduce electrostatic binding and/or change the conforma-
tion of the naked RNA so that binding propensity is origin of the resistance only to 4,6-linked aminoglyco-
sides exhibited by bacteria possessing a methyl at posi-disfavored.
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Table 3. Root-Mean-Square Deviations (Rmsd) Calculated between A Site Models
30S X-Ray Structure 30S X-Ray Structure 30S X-Ray Structure NMR Site 1 Site 2
without Antibiotic [34] with Paromomycin [19] with IF1 Factor [35] Structure [15] (Present Work) (Present Work)
30S X-ray structure 2.6 2.8 1.4 2.3 2.7
without antibiotic [34] — — — — —
30S X-ray structure with 0.6 1.9 2.7 0.9 0.7
paromomycin [19] 6.4 — 2.8 1.0 0.8
—
30S X-ray structure 1.0 1.1 3.0 2.0 2.0
with IF1 factor [35] 6.8 3.8 — — —
— —
NMR structure [15] 1.2 1.1 1.8 2.2 2.6
1.8 6.5 6.8 2.4 2.7
— 3.1 —
Site 1 1.0 0.8 1.5 1.0 0.8
5.4 2.0 3.7 5.2 0.8
— 1.1 — 3.2
Site 2 0.9 0.7 1.4 1.0 0.4
6.4 0.8 3.8 6.4 2.0
— 1.3 — 3.2 0.4
Root-mean-square deviations (rmsd) calculated (in A˚) between A site models of the available crystallographic and NMR structures, and the two sites
present in this structure (using residues 1405—1409 on the 5 side and residues 1491–1946 on the 3 side, with or without the paromomycin molecule).
A dash means the rmsd has not been calculated. All the rmsd are calculated using the software Lsqman [59].
Upper triangle of the table: rmsd after superimposition using every atom of all the residues either without antibiotic (first line) or with antibiotic (second
line, in bold).
Lower triangle of the table: rmsd after superimposition of the sugar and phosphate atoms of all the residues except adenines A1492 and A1493 (first line).
The rmsd between the two adenines (second line, in bold) and the rmsd between paromomycin residues (third line, in bold italic) are calculated in that
superimposition framework.
tion N7 of G1405 [37]. It is noteworthy that methylation on acetyl- and phosphotransferases inactivate ammonium
N1, N3, N2’, N6’, and hydroxyl 3 and 5” of the ribosta-N7 introduces a positive charge that creates an addi-
tional repulsion with the ammonium group N3”. mycin part [39], each time depriving the antibiotic of a
direct contact with the targeted A site.Bacteria have developed another strategy to resist to
aminoglycosides: enzymes specifically inactivate func-
tional groups on the aminoglycosides. It appears that A Particular Motif Involved in Packing Interactions
Packing interactions involve two modes of intermolecu-the so-modified functional groups are indeed all respon-
sible for direct contacts with the RNA. Enzymes such as lar contacts. Duplexes are stacked head-to-tail with a
Figure 5. Superimposition of the Different
Structures Containing the Paromomycin
Docked into the A Site.
(a) View of the A site as in Figure 3. Superim-
position of the X-ray structure of the 30S par-
ticle (magenta) and of the NMR structure
(gold) complexed to paromomycin over site
1 of the present structure (gray). The superim-
position has been calculated using the soft-
ware Lsqman [59] only with consideration of
the sugar and phosphate atoms of all the
residues (1405–1409 on the 5 side and 1491–
1496 on the 3 side) except adenines A1492
and A1493.
(b) View down the helical axis with the same
color code.




adenines A1492 and A1493 are protected from DMS-induced
methylation [10, 45]. These observations with others [14,
19, 46, 47] have led to the suggestion that those ade-
nines are involved in the decoding mechanism via their
hydrophilic base and sugar atoms. Thus, the two ade-
nines have been implicated in the interaction with the
2’ hydroxyls of the mRNA [47], and it has been further
shown that a conformational switch similar to that pro-
voked by cognate tRNA selection [48] occurs upon anti-
biotic binding. Carter and coworkers [19] were the first
to propose that the two adenines flip out in order to
contact both the tRNA and the mRNA via hydrogen
bonds involving the N1 atoms of the adenines and the
functional groups present in the shallow groove of the
codon-anticodon helix.
The present X-ray structure shows how paromomycin
Figure 6. Superimposition of Tobramycin Modeled on Paromomy-
promotes and stabilizes the bulging of the two adeninescin in the A Site
(Figure 7). The bulging out of A1492 and A1493 forces the
View toward the A site (site 1) along the helical axis following the
phosphate oxygens of residues 1492–1494 to turn insidecolor code of Figure 1b. The base pair C1496G1405 is shown in front
the pocket to make four direct hydrogen bonds towardwith thicker sticks. Rings I and II of tobramycin (with carbon atoms
in green) are superposed over rings I and II of paromomycin. rings I and II of paromomycin. The Watson-Crick sites
The tobramycin coordinates were obtained from [62]. of A1492 and A1493 are then able to bind another region
using an RNA recognition motif as suggested [19, 49].
The observed crystal packing offers a mode of recogni-
large pseudotwist angle (88), and the bulged adenines tion between the bulging adenines and the base pairs
of each site make similar but not identical contacts with within a helix. In three cases out of four (Figure 7), atoms
symmetry-related molecules (Figure 7a). The bulging ad- N1, N3, and O2’ of the bulging adenines are implicated.
enines of sites 1 and 2 bind to the shallow groove of An important aspect displayed by the structure is that
two stacked GC pairs belonging to symmetry-related the recognition mode is not stringent, since in site 2 the
molecules (Figure 7b). Each set of bulged adenines contacts are not direct but mediated by a string of water
forms a recurrent recognition motif [40, 41], i.e., the molecules. More than two months after submission of
tandem type II/type I interactions. This motif was first this work, two crystal structures of 30S particles in com-
predicted [42] and then observed in the hammerhead plex with mRNA and cognate tRNA in the A site, in the
ribozyme [43] and, in several occurrences, in the recent presence or absence of paromomycin, have been solved
structures of the ribosomal 50S and 30S particles [4, at 3.1–3.3 A˚ resolution [49]. In these structures, A1492 and
19]. The two adenines of site 1 (A36 and A37) form a set A1493 bulge out so that each adenine can form a set of
of tandem type II/type I interactions with the G32C10 tandem type II/type I interactions with A35-U2 and A36-U1,
and G33C9 pairs of a symmetry-related molecule (Figure the first two base pairs of a codon-anticodon minihelix.
7c). The two adenines of site 2 (A15 and A16) form equiva- In the present structure, the bulged adenines of each
lent consecutive type II/type I interactions with the minimal A site (sites 1 and 2) are involved in homologous
G11C31 and G12C30 pairs of another symmetry-related interactions (Figures 7b–7d). Indeed, in the present
molecule (Figure 7d). However, while A36 and A37 are structure, the bulged adenines of each site contact the
almost parallel to the two GC pairs they contact, A15 shallow groove of two GC pairs instead of A-U pairs.
and A16 approach their facing GC pairs with an angle This observation confirms the suggestions of the au-
close to 45 (Figure 7d). A necklace of water molecules thors [49] that a CG or GC pair at the first position
helps the accommodation of the longer distances be- of the anticodon-codon helix would form an additional
tween the corresponding hydrogen bond partners of A16 hydrogen bond from the N2 of the guanine to the N3 of
and G12C30 in site 2. The base C40 of a third symmetry- A1493. Furthermore, in the type II contact, the purine of
related molecule contacts a Hoogsteen site of A36 (Figure the Watson-Crick base pair (G32 in the present structure
7c), while the corresponding C40 of a fourth symmetry- or A35 in the 30S particle) attracts on the Hoogsteen side
related molecule is too far away to interact with A15 other interacting partners (water molecules and C40 in
in site 2 (Figure 7d). Crystal packing is based almost the present structure; G530, C518, and the hydroxyl group
exclusively on the interactions formed by the bulging of a serine in the 30S particle). The interactions observed
adenines which may thus constitute the driving force in the present structure and in the 30S particle [19, 49]
for crystallization and explain why no crystals could be are in agreement and are, therefore, at variance with
obtained in the absence of paromomycin. previous proposals for the decoding mechanism [46,
47]. The comparisons between the crystallographic re-
A Model for the Role of the Bulging Adenines sults obtained on the 30S particle with cognate tRNA
in the Decoding Mechanism binding to mRNA [49] and those of the present structure
The binding of an aminoglycoside molecule to the de- lead us to conclude that the observed crystal packing
coding A site increases the misincorporation of near- reflects the relevant biological system. However, some
cognate amino acids during translation [44]. In the pres- minor contribution to conformational variability of the ade-
nines is probably due to packing constraints, since theence of tRNA and mRNA, the N1 sites of the bulging
Complex between Paromomycin and Bacterial A Site
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Figure 7. Crystal Packing Interactions
(a) This view shows three duplexes down their
helical axes and their interaction with two
symmetry-related duplexes via the bulged
adenines. It shows how the bulged adenines
always point in the same directions within a
pseudocontinuous helix, as each pair of
bulged adenines interacts with GC pairs of
symmetrical duplexes forming an angle.
(b) Three-dimensional structure of the pack-
ing interactions observed in the crystal at the
central Watson-Crick domain of the duplex
(the inset on the left indicates the numbering
on a pseudo-secondary structure). The view
is perpendicular to the helix axis, down the
pseudo-two-fold symmetry axis, and toward
the shallow groove. The nucleotides are col-
ored according to the base type (guanine is
gray, cytosine is dark red, and adenine is
gold), red spheres indicate water molecule
positions, and ribbons (sketched as arrows
in the inset) join the phosphate atoms of each
separate chain.
(c) Close-up of the interactions (type I and
type II) between each adenine and its coun-
terpart GC pair in site 1. The hydrogen
bonds are represented by black dashed lines.
Hydrogen bond distances are indicated in
italic.
(d) Close-up of the interactions (type I and
type II) between each adenine and its coun-
terpart GC pair in site 2 (view as in Figure
7c). Adenines occupying equivalent positions
in sites 1 and 2 are displayed similarly. The
longer distance between A15 and C40 is shown
as a shaded dashed line.
two sets of bulging adenines present in the asymmetric Biological Implications
unit make slightly different intermolecular contacts.
It is interesting that, in the crystal structure of the 30S Targeting RNA has become one promising way of fight-
ing bacterial and viral infections. Aminoglycoside antibi-particle in complex with mRNA and cognate tRNA [49],
two magnesium ions (having occupations other than 1.0) otics are compounds that inhibit bacterial growth by
binding to specific sites on the ribosome. We have de-bind to the A site and, by forming contacts homologous
to those made by the ammonium group N3 of ring II to signed an RNA fragment containing twice the eubacte-
rial ribosomal A site that cocrystallized with two paromo-O1P(A1493), N7(G1494), and O2P(G1494), stabilize the bulging
conformation of the two adenines A1492 and A1493. Thus, mycin molecules. The structure of the complex reveals
new, intimate contacts between the aminoglycoside andas previously suggested [26, 27], the ammonium groups
of the aminoglycosides displace magnesium ions by its binding pocket in the deep groove of an RNA mole-
cule. An analysis of these interactions helps us to under-binding to sites occupied by the magnesium ions in the
uncomplexed molecule. stand the aminoglycoside specificity toward the pro-
karyotic A site and allows us to derive patterns ofOur study illustrates how properly selected RNA motifs
are able to assemble and form binding pockets with prop- recognition between aminoglycosides and RNA mole-
cules. First, recognition occurs between the puckerederties similar to those present in the original molecules
from which the RNA motifs are derived. Further, the pres- paromomycin ring I and A1408 via direct hydrogen bonds.
Second, the antibiotic exploits its own hydration shell andent structure constitutes another example of how crystal
packing exploits RNA-RNA self-assembly motifs occurring the typical RNA water hydration patterns in order to bind
specifically to its target. Finally, the binding modes of thein naturally folded RNA molecules. However, it is still rather
difficult to predict a priori the most appropriate self-assem- bulging adenines to the shallow grooves of GC pairs
constitute a model for the recognition between the A sitebly motif and the relative geometries among the unit cell
molecules for crystal engineering. and the anticodon-codon helix in the ribosome.
Structure
656
(starting at 3500 K–2500 K and slow cooling at 50 K/min) and manualBeyond the problem of the intricate and ever-evolving
rebuilding in the calculated A-weighted 3Fo2Fc and FoFc elec-resistance mechanism, a close analysis of the contacts
tron density maps. Occupancy factors were fixed to 1.0, while tem-and of the relations between them together with affinity
perature B factors were set to 30.0 A˚2 and then refined isotropically
measurements of different antibiotics on different A site on a 6–2.5 A˚ resolution range. The maps did not show any density
models [36] reveal ways to design alternative com- for the cytosine overhang on the 5 but showed clearly the density
for the paromycin in the two sites. The structure was refined (withpounds that will target RNA with efficiency.
CNS version 1.0) with neamine (containing only rings I and II of
paromomycin), then ribostamycin (containing rings I–III), and finallyExperimental Procedures
the full paromomycin molecule (with parameter and topology files
calculated on the XDICT server [58]). Subtle rearrangements of theRNA Synthesis, Purification, and Crystallization
substitutive groups on the antibiotic (especially the O6’ position)Various sequences were designed to incorporate the nucleotides
and at particular places on the RNA (the AA bulge or the UoU pair)of the E. coli A site necessary for the interaction with the aminoglyco-
could help to properly place the molecule in the density. Refinementsides [13]. The asymmetrical loop of the A site (13 nucleotides) was
was then carefully pursued with the energy minimization protocolinserted between Watson-Crick pairs in sequences designed to fold
(8–2.5 A˚ / 4 cycles of 200 steps) after water molecule addition toas double helices and not as hairpin structures. These RNA se-
reach final R  20.6% and Rfree  24.7%. The final model containsquences containing different lengths and ends were checked for
900 RNA atoms, 84 paromomycin atoms, and 54 water molecules.alternative two-dimentional foldings using the program MFOLD [50].
These sequences were synthesized via the standard phosphorami-
dite chemistry [51] on an automated DNA/RNA synthesiser (Applied
AcknowledgmentsBiosystems 392) or ordered from Dharmacon Research (Boulder, CO).
Oligomers were purified to crystallization quality by denaturing
We are grateful to Vincent Mikol and Jean-Pierre Guilloteau atgel electrophoresis (20% acrylamide:bisacrylmamide [19:1] and 8
Aventis for encouragement and support. We thank Philippe WolffM urea) with TBE buffer (9 mM Tris borate [pH 8.3] and 0.2 mM
for the synthesis of the oligoribonucleotides, Andreas Werner forEDTA) at 50C–55C. RNA oligomers were recovered by the “crush
the assistance with the optimization protocols, Nu¨khet Cavusogluand soak” method at 4C in 10 mM Tris (pH 7.5), 200 mM NaCl, and
and Alain van Dorsselaer from the Laboratoire de Spectrome´trie de0.5 mM Na EDTA during 48 hr with one buffer exchange followed
Masse Bio-organique (UMR 7509, CNRS, Strasbourg, France) forby ethanol precipitation. The pellets were washed with ethanol 95%,
the MALDI-TOF experiments, and Pascal Auffinger and Venki Rama-evaporated to dryness, and resuspended in milliQ water. Prior to
krishnan for discussions and careful reading of the manuscript. Wecrystallization experiments, paromomycin (Paromomycin sulfate,
gratefully acknowledge the help of Philippe Dumas, Eric Ennifar,Fluka) was dissolved at 70 mM in 50 mM Na cacodylate buffer (pH
Benoıˆt Masquida, and the people of beamline ID14-1 at European6.4), and the RNA was annealed by heating at 85C for 2 min followed
Synchrotron Radiation Facility (Grenoble, France) with data collectionby slow cooling (2 hr 30 min) to 37C. Addition of paromomycin
and refinement. Q.V. is supported by a Bourse Docteur-Inge´nieur(2:1 ratio with RNA) occurred at 37C (5 min). Slow cooling then
Aventis/CNRS.proceeded to 21C. Hanging drops of 2 	l containing 1 volume of
crystallization solution (1.5%–5% MPD [Fluka], 1%–2% glycerol, 2
mM paromomycin, 100–250 mM NaCl, 0–10 mM MgSO4, and 50 mM Received: February 26, 2001
Na cacodylate [pH 6.4]) plus 1 volume of annealing solution (1 mM Revised: June 25, 2001
RNA, 2 mM paromomycin, 12.5 mM NaCl, 5 mM MgSO4, and 75 Accepted: June 27, 2001
mM Na cacodylate [pH 6.4]) were equilibrated against 500 	l 40%–
60% MPD. Plates too thin to be analyzed on a conventional diffracto-
meter crystallized in 2–3 days. The optimization of the crystallization References
conditions led to larger plates.
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